Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$EOLS

Evolus, Inc. Common Stock

XNAS

$5.80+4.69%+$0.2600Prev $5.54LIVE Full chart Live alerts
No recent price bars, the chart lights up when EOLS starts printing.

Why is EOLS up today? It is at $5.80 (+4.69%), and our scanner flagged it 4 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment EOLS spikes, and full due diligence on EOLS — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $EOLS alerts the moment volume spikes

Our scanner flagged $EOLS 4 times in the last 30 days. Create a free account to track $EOLS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$5.80
Change today
+4.69%
Previous close
$5.54
52-week range
$3.86 – $10.20
Valuation & dividend
Market cap
$365M
Ownership & volume
Shares outstanding
65.9M
SEC · as of 2026-04-30
Insider ownership
5.2%
DEF 14A · 2026-04-29
Institutional own.
74.94%
Total held
80.1%
Tradeable float
13.1M
20% of shares · after 5% insiders + 75% institutions
Short interest
6.0M
▲ +2% vs prior · as of 2026-06-30
Short % of float
46.0%
Days to cover
7.3d
Avg daily volume
1.2M
Next earnings
Aug 4 · in 14d
Classification
Exchange
XNAS

Get free EOLS + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $EOLS up today?

2 alerts today29.6x RVOL

EOLS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on EOLS today, peaking at 29.6x its normal volume.

Likely catalystClinical / FDA update, from the latest SEC filing. Read it →
Why is $EOLS moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileLow float · 13.1M sh🔥 Heavily shorted · 46% of floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201

Insiders

0 buys, 0 sells last 3 months (10/7 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Moatazedi David
Officer
Sold (automatic/other)-14K
0.02% of company
sold 2.2%605K$65K
at $4.75
Mar 20, 26
Avelar Rui
Officer
Sold (automatic/other)-3Ksold 0.7%427K$15K
at $4.75
Mar 20, 26
Moatazedi David
Officer
Sold (automatic/other)-117K
0.2% of company
sold 16%618K$571K
at $4.89
Mar 17, 26
Avelar Rui
Officer
Sold (automatic/other)-30K
0.05% of company
sold 6.5%431K$147K
at $4.89
Mar 17, 26
Avelar Rui
Officer
Other9K
0.01% of company
added 1.9%461Kn/aMar 16, 26
Moatazedi David
Officer
Other67K
0.1% of company
added 10%735Kn/aMar 16, 26
Avelar Rui
Officer
Acquired (grant/award)+95K
0.1% of company
added 27%452Kn/aFeb 17, 26
Gill David N
Director
Acquired (grant/award)+46K
0.07% of company
added 100%87Kn/aFeb 17, 26
Moatazedi David
Officer
Acquired (grant/award)+313K
0.5% of company
added 88%668Kn/aFeb 17, 26
Malik Vikram
Director
Acquired (grant/award)+46K
0.07% of company
added 17%321Kn/aFeb 17, 26
Mitchell Tatjana
Officer
Acquired (grant/award)+121K
0.2% of company
added 100%226Kn/aFeb 17, 26
White Albert G Iii
Director
Acquired (grant/award)+46K
0.07% of company
added 90%96Kn/aFeb 17, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Active shelf

Active shelf on file — the company can issue new shares on demand (valid ~3 years). If $EOLS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$EOLS Sentiment

Bullish
Bearish91Bullish
📰 News: 1 bull · 0 bearToday: +4.7%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$EOLS Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 7h ago +1.9% vs EMA
EOLS 200EMA (5m) Trending · 62 bars · L3 · +1.89% above EMA · slope +0.27%
at $5.82
Alert· 7h ago +1.1% vs EMA
EOLS 50EMA (5m) Trending · 72 bars · L3 · +1.06% above EMA · slope +0.58%
at $5.82
Alert· 7h ago +1.7% vs EMA
EOLS 200EMA (1m) Trending · 177 bars · L4 · +1.72% above EMA · slope +0.31%
at $5.82
Alert· 7h ago 2.0× RVOL
EOLS hit 2.044x RVOL at 3:29 PM ET
at $5.79
Alert· 11h ago 29.6× RVOL
EOLS hit 29.652x RVOL at 11:51 AM ET
at $5.82
Alert· 1d ago -2.6% vs EMA
$EOLS near 200 EMA: -2.56% from 200 EMA at 1:31 PM ET
at $5.45
Alert· 1d ago 10.3× RVOL
EOLS hit 10.259x RVOL at 1:31 PM ET
at $5.45
Alert· 1d ago 10.3× RVOL
EOLS hit 10.347x RVOL at 12:35 PM ET
at $5.50
News· SEC EDGAR· 13d ago
Evolus, Inc. filed an 8-K: Material Agreement, Regulation FD Disclosure
News· SEC EDGAR· 39d ago
Evolus, Inc. filed an 8-K: Shareholder Vote
News· GlobeNewswire Inc.· 47d ago Neutral
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
News· Benzinga· 60d ago Bullish
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
News· SEC EDGAR· 78d ago
Evolus, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 78d ago
Evolus, Inc. filed an 8-K: Results of Operations, Regulation FD Disclosure
News· The Motley Fool· 205d ago Neutral
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
News· GlobeNewswire Inc.· 214d ago Neutral
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

EOLS stock FAQ

Why is $EOLS up today?

EOLS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on EOLS today, peaking at 29.6x its normal volume.

What is the EOLS stock price today?

EOLS last traded at $5.80, up 4.69% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does EOLS report earnings?

Evolus, Inc. Common Stock (EOLS) is next expected to report earnings on Tuesday, August 4, 2026, about 14 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live EOLS alerts?

The EOLS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged EOLS 4 times in the last 30 days.

What exchange is EOLS on?

EOLS (Evolus, Inc. Common Stock) trades on XNAS, with a market cap of about $365M.

Is EOLS good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge EOLS for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.